Is Rhythm Biosciences Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Rhythm Biosciences Ltd (RHY.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Rhythm Biosciences Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Rhythm Biosciences Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Rhythm Biosciences Ltd?

Muslim investors may consider investing in Rhythm Biosciences Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Rhythm Biosciences Ltd classified as HALAL?

Musaffa determines the Shariah status of Rhythm Biosciences Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Rhythm Biosciences Ltd updated?

The Shariah compliance status of Rhythm Biosciences Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Rhythm Biosciences Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Rhythm Biosciences Ltd?

You can check the latest Shariah compliance status of Rhythm Biosciences Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RHY.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 29, 2025

Report Source: 2025 2nd Quarter Report

Rhythm Biosciences Ltd. Stock Analysis RHY.AX

Australia Health Care Nano Cap Report: Q2, 2025

Rhythm Biosciences Ltd. engages in the research, development, and commercialization of medical diagnostics technologies. The firm is engaged in delivering simple, affordable blood tests for accurate and early detection of cancers. The company is focused on improving patient outcomes through detection at the earliest possible stage, reducing the global burden of cancer and saving lives. The Company’s blood-based technology, a blood test for the detection of Colorectal Cancer (CRC). The ColoSTAT Test-Kit measures five specific protein biomarkers that indicate the likelihood of CRC. The test is an alternative for individuals who are unable or unwilling to participate in current screening programs. The company is being updated to meet the IVDR (In vitro diagnostic medical devices regulation) regulatory standards. Its geneType platform personalized predictive test portfolio that uses a combination of genomic and clinical information to predict risk of chronic disease development.

Key Statistics of Rhythm Biosciences Ltd (RHY.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.14AUD0.14

Today's Open

AUD0.14

Volume

210.62K

P/E Ratio (TTM)

52 Week Range

AUD0.05AUD0.28

Market Cap

49.15M

Avg. Volume

283.17K

Dividend Yield

Financial Metrics & Statements of Rhythm Biosciences Ltd (RHY.AX)

FAQ's for Rhythm Biosciences Ltd (RHY.AX)

According to Musaffa’s Shariah screening methodology, Rhythm Biosciences Ltd (RHY.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.